UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

What Have We Learnt about BCG Vaccination in the Last 20 Years?

Frontiers in immunology, 2017-09, Vol.8, p.1134-1134

2017

Volltextzugriff (PDF)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?

EBioMedicine, 2022-05, Vol.79, p.103993-103993, Article 103993

2022

Volltextzugriff (PDF)

Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response

The Journal of infectious diseases, 2013-01, Vol.207 (1), p.18-29

2013

Volltextzugriff (PDF)

Tuberculosis vaccines: Opportunities and challenges

Respirology (Carlton, Vic.), 2018-04, Vol.23 (4), p.359-368

2018

Volltextzugriff (PDF)

Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation

Frontiers in immunology, 2017-06, Vol.8, p.644-644

2017

Volltextzugriff (PDF)

How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS

Frontiers in neurology, 2020-08, Vol.11, p.826-826

2020

Volltextzugriff (PDF)

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment

PloS one, 2015-09, Vol.10 (9), p.e0137646-e0137646

2015

Volltextzugriff (PDF)

Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia

PLoS neglected tropical diseases, 2017-10, Vol.11 (10), p.e0006011

2017

Volltextzugriff (PDF)

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Frontiers in immunology, 2019-04, Vol.10, p.796

2019

Volltextzugriff (PDF)

A next generation BCG vaccine moves forward

The Lancet infectious diseases, 2022-10, Vol.22 (10), p.1404-1406

Dockrell, Hazel M

2022

Volltextzugriff (PDF)

Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function

PLoS neglected tropical diseases, 2022-07, Vol.16 (7), p.e0010641-e0010641

2022

Volltextzugriff (PDF)

Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions

PLoS neglected tropical diseases, 2017-12, Vol.11 (12), p.e0006121

2017

Volltextzugriff (PDF)

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania

BMC genomics, 2020-02, Vol.21 (1), p.174-15, Article 174

2020

Volltextzugriff (PDF)

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults

PloS one, 2013-11, Vol.8 (11), p.e79742-e79742

2013

Volltextzugriff (PDF)

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines

PloS one, 2015-09, Vol.10 (9), p.e0138042-e0138042

2015

Volltextzugriff (PDF)

Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity

PloS one, 2014-09, Vol.9 (9), p.e106796-e106796

2014

Volltextzugriff (PDF)

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda

PloS one, 2016-01, Vol.11 (1), p.e0146098-e0146098

2016

Volltextzugriff (PDF)

Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?

Vaccine, 2022-03, Vol.40 (11), p.1525-1533

2022

Volltextzugriff (PDF)

Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa

Frontiers in immunology, 2021-02, Vol.12, p.639174-639174

2021

Volltextzugriff (PDF)

Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification

Frontiers in immunology, 2021-03, Vol.12, p.637164-637164

2021

Volltextzugriff (PDF)

Working together toward vaccines and biomarkers in the real world

Human vaccines & immunotherapeutics, 2017-07, Vol.13 (7), p.1492-1494

Dockrell, Hazel M.

2017

Volltextzugriff (PDF)

Complement C1q expression in Erythema nodosum leprosum

PLoS neglected tropical diseases, 2018-03, Vol.12 (3), p.e0006321-e0006321

2018

Volltextzugriff (PDF)

Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries

PloS one, 2016-05, Vol.11 (5), p.e0154571-e0154571

2016

Volltextzugriff (PDF)

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials

PloS one, 2017-10, Vol.12 (10), p.e0184391-e0184391

2017

Volltextzugriff (PDF)

Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease

Frontiers in immunology, 2021-02, Vol.12, p.607827-607827

2021

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(139)
Humans
(126)
Immunology
(102)
Tuberculosis
(90)
Infectious Diseases
(76)
Mycobacterium Tuberculosis
(66)
Female
(59)
Male
(59)
Adult
(58)
Mycobacterium Tuberculosis - Immunology
(43)
Microbiology
(42)
Cytokines
(36)
Adolescent
(35)
Middle Aged
(34)
Tuberculosis - Immunology
(33)
Antigens
(31)
Biomarkers
(31)
Infections
(31)
Vaccines
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

What Have We Learnt about BCG Vaccination in the Last 20 Years?

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?

Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response

Tuberculosis vaccines: Opportunities and challenges

Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation

How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment

Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

A next generation BCG vaccine moves forward

Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function

Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines

Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda

Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?

Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa

Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification

Working together toward vaccines and biomarkers in the real world

Complement C1q expression in Erythema nodosum leprosum

Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials

Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease

Suchergebnisse filtern